| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| NEUTRAL | SELL | SELL | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 11.50▲ | 11.48▲ | 11.56▲ | 11.97▼ | 11.82▼ |
| MA10 | 11.55▲ | 11.80▼ | 12.05▼ | 11.09▲ | 10.12▲ |
| MA20 | 12.06▼ | 12.01▼ | 11.81▼ | 12.06▼ | 8.64▲ |
| MA50 | 11.55▲ | 11.17▲ | 11.29▲ | 9.81▲ | N/A |
| MA100 | 11.01▲ | 11.94▼ | 11.87▼ | 8.17▲ | N/A |
| MA200 | 12.01▼ | 10.82▲ | 9.76▲ | N/A | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.091▼ | -0.144▼ | -0.098▼ | -0.123▼ | 0.342▲ |
| RSI | 48.299▼ | 49.361▼ | 49.975▼ | 53.920▲ | 64.383▲ |
| STOCH | 41.878 | 11.966▼ | 12.380▼ | 60.020 | 64.437 |
| WILL %R | -70.745 | -70.745 | -70.745 | -49.980 | -40.168 |
| CCI | -29.841 | -47.374 | -57.740 | -24.817 | 78.592 |
|
Monday, September 29, 2025 02:05 PM
R&D Expenses: Research and development expenses were $9.0 million for the year ended June 30, 2025, compared to $9.4 million for the year ended June 30, 2024. The decrease of $0.4 million was ...
|
|
Thursday, September 04, 2025 07:25 AM
Neuphoria Therapeutics (NEUP) announced the achievement of target enrollment of 332 participants in the AFFIRM-1 Phase 3 trial evaluating lead candidate BNC-210 as a first-in-class, acute, “as needed” ...
|
|
Thursday, September 04, 2025 12:00 AM
BURLINGTON, Mass., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Neuphoria Therapeutics Inc. (Nasdaq: NEUP) (“Neuphoria” or the “Company”), a clinical-stage biotechnology company developing impactful treatments ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 30/09/25 | 11.24 | 11.79 | 10.47 | 11.79 | 57,902 |
| 29/09/25 | 12.25 | 12.913 | 11.25 | 11.86 | 49,500 |
| 26/09/25 | 12.96 | 13.28 | 12.1273 | 12.31 | 50,294 |
| 25/09/25 | 12.00 | 13.25 | 11.75 | 12.45 | 96,234 |
| 24/09/25 | 11.48 | 11.775 | 10.908 | 11.45 | 38,000 |
| 23/09/25 | 9.94 | 12.035 | 9.88 | 11.04 | 150,700 |
| 22/09/25 | 10.09 | 10.394 | 9.5118 | 9.86 | 56,189 |
| 19/09/25 | 9.81 | 10.53 | 9.80 | 10.095 | 73,400 |
| 18/09/25 | 10.83 | 11.06 | 9.28 | 9.40 | 113,900 |
| 17/09/25 | 12.67 | 12.67 | 10.63 | 10.63 | 91,749 |
|
|
||||
|
|
||||
|
|